The Initiative for MPTs (IMPT) is a global learning network that aims to advance multipurpose prevention technologies (MPTs) – an innovative class of products that deliver varied combinations of HIV prevention, other STI prevention, and contraception and will improve the lives of women and families worldwide.

Image by Edu Lauton
Photograph: Edu Lauton https://unsplash.com/@edulauton
Our MPT Database features innovative female-initiated prevention products in the pipeline.
outreach
Search for resources on global MPT research & advocacy, including key IMPT publications.
Lets Talk MPTs
Watch the "Let's Talk MPTs" webinar on vaginal microbiota & MPTs from Dec 10th.
interactive mapping tool
Explore the interactive mapping tool which illustrates HIV prevalence in women and the market for contraception.
Video-MPTS for a better World
IMPT video: MPTs for a Better World, new technologies reduce unintended pregnancy, HIV & STIs.

Highlights

Attending HIVR4P 2021? Make sure to join these virtual symposiums and poster exhibitions on MPTs!
Read our Call to Action with recommendations for bridging gaps to ensure MPTs reach the hands of women.
Read our recommended MPT action areas for combining non-hormonal contraceptives and anti-infective prevention products.
Read our recommended MPT action areas for combining hormonal contraceptives and antiretroviral drugs. 
Exploring career pathways in MPT research? See resources here!
Browse funding opportunities to support your MPT work.
Groundbreaking HIV prevention findings: Interim analysis from HPTN 084 study on long-acting injectable cabotegravir in women.
Evofem Biosciences secures $25M investment to advance its innovative MPT product pipeline
IMPT Director Bethany Young Holt featured in MCI Webinar: MPTs & Male Contraception
On the IMPT Blog: Updated MPT Product Development Database
New research by the Population Council estimates the market size for the Dual Prevention Pill (DPP) Regimen
New Policy Brief by WHO & UNAIDS promotes integration of HIV prevention and contraceptive services, including MPTs.
New HIV prevention findings: Initial HPTN 083 results show long-acting injectable cabotegravir is safe & effective as PrEP for MSM; linked to sister study in women.
"It's all in a decade's work": A Ten-Year Retrospective Report on the IMPT.

The IMPT is the first & only initiative dedicated to advancing the field of multipurpose prevention technologies (MPTs), products that combine HIV prevention, other STI prevention, and contraception.

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825
IMPT@cami-health.org

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
© Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.